Patent details

EP1713459 Title: USE OF SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR AGONISTS FOR THE TREATMENT OF BRAIN DEGENERATIVE DISEASES

Basic Information

Publication number:
EP1713459
PCT Application Number:
PCT/EP/2004/014436
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP048040372
PCT Publication Number:
WO/2005/058295
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR AGONISTS FOR THE TREATMENT OF BRAIN DEGENERATIVE DISEASES
French Title of Invention:
UTILISATION D'AGONISTES DU RECEPTEUR DE SPHINGOSINE-1-PHOSPHATE POUR LE TRAITEMENT DE MALADIES DEGENERATIVES DES FONCTIONS CEREBRALES
German Title of Invention:
VERWENDUNG VON SPHINGOSIN-1-PHOSPHAT (S1P) REZEPTOR-AGONISTEN ZUR BEHANDLUNG VON DEGENERATIVEN GEHIRNERKRANKUNGEN
SPC Number:

Dates

Filing date:
17/12/2004
Grant date:
21/07/2010
EP Publication Date:
21/07/2010
PCT Publication Date:
30/06/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/10/2006
EP B1 Publication Date:
21/07/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/12/2010
Expiration date:
17/12/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/12/2004
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
Novartis Pharma GmbH
Address:
Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:
KANEIDER Nicole
Address:
Austria (AT)

2

Name:
WIEDERMANN Christian, J.
Address:
Austria (AT)

3

Name:
BRINKMANN Volker
Address:
Germany (DE)

Priority

Priority Number:
0329498
Priority Date:
19/12/2003
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/133;
Filing date Document type Number of pages